Ken is a private equity investment professional who brings a wealth of origination, M&A execution and management expertise.
Having joined GHO in 2016, Ken is currently a member of the board at Sanner, Linimed, Alcaliber and Linneo Health, having previously also worked with Quotient Sciences.
Prior to GHO, he was with Stirling Square Capital Partners in London where he was responsible for mid-market pan-European buyouts. Before Stirling, Ken was a private equity investor with Odewald & Compagnie in Berlin working on German Mittelstand transactions, having started his career as a leveraged finance banker with Citigroup and Banc of America Securities in London and New York.
Ken has an MSc in Investment Management from Cass Business School and graduated from the University of Buckingham with a BSc in Business Economics. A native German speaker, with conversational Spanish, Ken has lived and worked in the UK, USA and Germany.